世界のデフェラシロクスAPI市場インサイト・予測(~2027)

QYResearchが発行した調査報告書(QY21AUG1082)
◆英語タイトル:Global Deferasirox API Market Insights and Forecast to 2027
◆商品コード:QY21AUG1082
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年8月(※2024年版があります。お問い合わせください。)
◆ページ数:129
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:化学&材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはデフェラシロクスAPIの世界市場の現状について調査・分析し、2027年までの市場を予測しました。デフェラシロクスAPIの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模(純度≥98%、純度<98%)、用途別市場規模(デフェラシロクス錠、その他)、主要地域別市場規模(北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ)、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・デフェラシロクスAPIの世界市場概要
・メーカー別の競争状況、市場シェア
・デフェラシロクスAPIの種類別市場規模:純度≥98%、純度<98%
・デフェラシロクスAPIの用途別市場規模:デフェラシロクス錠、その他
・北米のデフェラシロクスAPI市場規模2016-2027:種類別、用途別、国別(アメリカ、カナダ)
・ヨーロッパのデフェラシロクスAPI市場規模2016-2027:種類別、用途別、国別(ドイツ、フランス、イギリス)
・アジアのデフェラシロクスAPI市場規模2016-2027:種類別、用途別、国別(日本、中国、インド、韓国)
・中南米のデフェラシロクスAPI市場規模2016-2027:種類別、用途別、国別(メキシコ、ブラジル)
・中東・アフリカのデフェラシロクスAPI市場規模2016-2027:種類別、用途別、国別(トルコ、サウジアラビア)
・企業情報:Piramal Enterprises Limited、Alkaloids Corporation、Zhejiang Hengkang Pharmaceutical、Om Pharmaceutical Industries、Teva API、Symed Labs Limited、Neuland Laboratories、Parabolic Drugs Limited、YUNG ZIP CHEMICAL INDUSTRIAL、Erregierre SpA、Glenmark Pharmaceuticals、Cipla、Sun Pharmaceutical Industries Ltd.、Jubilant Pharma、CTX Lifesciences、Waterstone Pharmaceuticals Inc.、Bal Pharma Ltd.、Curequest Lifescience
・デフェラシロクスAPIのバリューチェーン・販売チャネル分析
・デフェラシロクスAPIの世界市場動向
【レポートの概要】

Deferasirox is a synthetic, orally bioavailable, achiral, tridentate triazole derived from salicylic acid with iron-chelating activity. Deferasirox chelates iron at a 2:1 (ligand:iron) ratio. Because of its oral availability and long plasma half-life, this agent may be superior to desferrioxamine (desferal, DFO), which is orally inactive and has a short plasma half-life.

Market Analysis and Insights: Global Deferasirox API Market
The global Deferasirox API market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Deferasirox API Scope and Segment
Deferasirox API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Deferasirox API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Purity≥98%
Purity<98% Segment by Application Deferasirox Tablets Others By Company Piramal Enterprises Limited Alkaloids Corporation Zhejiang Hengkang Pharmaceutical Om Pharmaceutical Industries Teva API Symed Labs Limited Neuland Laboratories Parabolic Drugs Limited YUNG ZIP CHEMICAL INDUSTRIAL Erregierre SpA Glenmark Pharmaceuticals Cipla Sun Pharmaceutical Industries Ltd. Jubilant Pharma CTX Lifesciences Waterstone Pharmaceuticals Inc. Bal Pharma Ltd. Curequest Lifescience Production by Region Europe China China Taiwan India Consumption by Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE

【レポートの目次】

1 Study Coverage
1.1 Deferasirox API Product Introduction
1.2 Market by Type
1.2.1 Global Deferasirox API Market Size Growth Rate by Type
1.2.2 Purity≥98%
1.2.3 Purity<98% 1.3 Market by Application 1.3.1 Global Deferasirox API Market Size Growth Rate by Application 1.3.2 Deferasirox Tablets 1.3.3 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Deferasirox API Production 2.1 Global Deferasirox API Production Capacity (2016-2027) 2.2 Global Deferasirox API Production by Region: 2016 VS 2021 VS 2027 2.3 Global Deferasirox API Production by Region 2.3.1 Global Deferasirox API Historic Production by Region (2016-2021) 2.3.2 Global Deferasirox API Forecasted Production by Region (2022-2027) 2.4 Europe 2.5 China 2.6 China Taiwan 2.7 India 3 Global Deferasirox API Sales in Volume & Value Estimates and Forecasts 3.1 Global Deferasirox API Sales Estimates and Forecasts 2016-2027 3.2 Global Deferasirox API Revenue Estimates and Forecasts 2016-2027 3.3 Global Deferasirox API Revenue by Region: 2016 VS 2021 VS 2027 3.4 Global Top Deferasirox API Regions by Sales 3.4.1 Global Top Deferasirox API Regions by Sales (2016-2021) 3.4.2 Global Top Deferasirox API Regions by Sales (2022-2027) 3.5 Global Top Deferasirox API Regions by Revenue 3.5.1 Global Top Deferasirox API Regions by Revenue (2016-2021) 3.5.2 Global Top Deferasirox API Regions by Revenue (2022-2027) 3.6 North America 3.7 Europe 3.8 Asia-Pacific 3.9 Latin America 3.10 Middle East & Africa 4 Competition by Manufactures 4.1 Global Deferasirox API Production Capacity by Manufacturers 4.2 Global Deferasirox API Sales by Manufacturers 4.2.1 Global Top Deferasirox API Manufacturers by Sales (2016-2021) 4.2.2 Global Top Deferasirox API Manufacturers Market Share by Sales (2016-2021) 4.2.3 Global Top 10 and Top 5 Companies by Deferasirox API Sales in 2020 4.3 Global Deferasirox API Revenue by Manufacturers 4.3.1 Global Top Deferasirox API Manufacturers by Revenue (2016-2021) 4.3.2 Global Top Deferasirox API Manufacturers Market Share by Revenue (2016-2021) 4.3.3 Global Top 10 and Top 5 Companies by Deferasirox API Revenue in 2020 4.4 Global Deferasirox API Sales Price by Manufacturers 4.5 Analysis of Competitive Landscape 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 4.5.2 Global Deferasirox API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.5.3 Global Deferasirox API Manufacturers Geographical Distribution 4.6 Mergers & Acquisitions, Expansion Plans 5 Market Size by Type 5.1 Global Deferasirox API Sales by Type 5.1.1 Global Deferasirox API Historical Sales by Type (2016-2021) 5.1.2 Global Deferasirox API Forecasted Sales by Type (2022-2027) 5.1.3 Global Deferasirox API Sales Market Share by Type (2016-2027) 5.2 Global Deferasirox API Revenue by Type 5.2.1 Global Deferasirox API Historical Revenue by Type (2016-2021) 5.2.2 Global Deferasirox API Forecasted Revenue by Type (2022-2027) 5.2.3 Global Deferasirox API Revenue Market Share by Type (2016-2027) 5.3 Global Deferasirox API Price by Type 5.3.1 Global Deferasirox API Price by Type (2016-2021) 5.3.2 Global Deferasirox API Price Forecast by Type (2022-2027) 6 Market Size by Application 6.1 Global Deferasirox API Sales by Application 6.1.1 Global Deferasirox API Historical Sales by Application (2016-2021) 6.1.2 Global Deferasirox API Forecasted Sales by Application (2022-2027) 6.1.3 Global Deferasirox API Sales Market Share by Application (2016-2027) 6.2 Global Deferasirox API Revenue by Application 6.2.1 Global Deferasirox API Historical Revenue by Application (2016-2021) 6.2.2 Global Deferasirox API Forecasted Revenue by Application (2022-2027) 6.2.3 Global Deferasirox API Revenue Market Share by Application (2016-2027) 6.3 Global Deferasirox API Price by Application 6.3.1 Global Deferasirox API Price by Application (2016-2021) 6.3.2 Global Deferasirox API Price Forecast by Application (2022-2027) 7 North America 7.1 North America Deferasirox API Market Size by Type 7.1.1 North America Deferasirox API Sales by Type (2016-2027) 7.1.2 North America Deferasirox API Revenue by Type (2016-2027) 7.2 North America Deferasirox API Market Size by Application 7.2.1 North America Deferasirox API Sales by Application (2016-2027) 7.2.2 North America Deferasirox API Revenue by Application (2016-2027) 7.3 North America Deferasirox API Sales by Country 7.3.1 North America Deferasirox API Sales by Country (2016-2027) 7.3.2 North America Deferasirox API Revenue by Country (2016-2027) 7.3.3 United States 7.3.4 Canada 8 Europe 8.1 Europe Deferasirox API Market Size by Type 8.1.1 Europe Deferasirox API Sales by Type (2016-2027) 8.1.2 Europe Deferasirox API Revenue by Type (2016-2027) 8.2 Europe Deferasirox API Market Size by Application 8.2.1 Europe Deferasirox API Sales by Application (2016-2027) 8.2.2 Europe Deferasirox API Revenue by Application (2016-2027) 8.3 Europe Deferasirox API Sales by Country 8.3.1 Europe Deferasirox API Sales by Country (2016-2027) 8.3.2 Europe Deferasirox API Revenue by Country (2016-2027) 8.3.3 Germany 8.3.4 France 8.3.5 U.K. 8.3.6 Italy 8.3.7 Russia 9 Asia Pacific 9.1 Asia Pacific Deferasirox API Market Size by Type 9.1.1 Asia Pacific Deferasirox API Sales by Type (2016-2027) 9.1.2 Asia Pacific Deferasirox API Revenue by Type (2016-2027) 9.2 Asia Pacific Deferasirox API Market Size by Application 9.2.1 Asia Pacific Deferasirox API Sales by Application (2016-2027) 9.2.2 Asia Pacific Deferasirox API Revenue by Application (2016-2027) 9.3 Asia Pacific Deferasirox API Sales by Region 9.3.1 Asia Pacific Deferasirox API Sales by Region (2016-2027) 9.3.2 Asia Pacific Deferasirox API Revenue by Region (2016-2027) 9.3.3 China 9.3.4 Japan 9.3.5 South Korea 9.3.6 India 9.3.7 Australia 9.3.8 China Taiwan 9.3.9 Indonesia 9.3.10 Thailand 9.3.11 Malaysia 10 Latin America 10.1 Latin America Deferasirox API Market Size by Type 10.1.1 Latin America Deferasirox API Sales by Type (2016-2027) 10.1.2 Latin America Deferasirox API Revenue by Type (2016-2027) 10.2 Latin America Deferasirox API Market Size by Application 10.2.1 Latin America Deferasirox API Sales by Application (2016-2027) 10.2.2 Latin America Deferasirox API Revenue by Application (2016-2027) 10.3 Latin America Deferasirox API Sales by Country 10.3.1 Latin America Deferasirox API Sales by Country (2016-2027) 10.3.2 Latin America Deferasirox API Revenue by Country (2016-2027) 10.3.3 Mexico 10.3.4 Brazil 10.3.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Deferasirox API Market Size by Type 11.1.1 Middle East and Africa Deferasirox API Sales by Type (2016-2027) 11.1.2 Middle East and Africa Deferasirox API Revenue by Type (2016-2027) 11.2 Middle East and Africa Deferasirox API Market Size by Application 11.2.1 Middle East and Africa Deferasirox API Sales by Application (2016-2027) 11.2.2 Middle East and Africa Deferasirox API Revenue by Application (2016-2027) 11.3 Middle East and Africa Deferasirox API Sales by Country 11.3.1 Middle East and Africa Deferasirox API Sales by Country (2016-2027) 11.3.2 Middle East and Africa Deferasirox API Revenue by Country (2016-2027) 11.3.3 Turkey 11.3.4 Saudi Arabia 11.3.5 UAE 12 Corporate Profiles 12.1 Piramal Enterprises Limited 12.1.1 Piramal Enterprises Limited Corporation Information 12.1.2 Piramal Enterprises Limited Overview 12.1.3 Piramal Enterprises Limited Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.1.4 Piramal Enterprises Limited Deferasirox API Product Description 12.1.5 Piramal Enterprises Limited Recent Developments 12.2 Alkaloids Corporation 12.2.1 Alkaloids Corporation Corporation Information 12.2.2 Alkaloids Corporation Overview 12.2.3 Alkaloids Corporation Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.2.4 Alkaloids Corporation Deferasirox API Product Description 12.2.5 Alkaloids Corporation Recent Developments 12.3 Zhejiang Hengkang Pharmaceutical 12.3.1 Zhejiang Hengkang Pharmaceutical Corporation Information 12.3.2 Zhejiang Hengkang Pharmaceutical Overview 12.3.3 Zhejiang Hengkang Pharmaceutical Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.3.4 Zhejiang Hengkang Pharmaceutical Deferasirox API Product Description 12.3.5 Zhejiang Hengkang Pharmaceutical Recent Developments 12.4 Om Pharmaceutical Industries 12.4.1 Om Pharmaceutical Industries Corporation Information 12.4.2 Om Pharmaceutical Industries Overview 12.4.3 Om Pharmaceutical Industries Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.4.4 Om Pharmaceutical Industries Deferasirox API Product Description 12.4.5 Om Pharmaceutical Industries Recent Developments 12.5 Teva API 12.5.1 Teva API Corporation Information 12.5.2 Teva API Overview 12.5.3 Teva API Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.5.4 Teva API Deferasirox API Product Description 12.5.5 Teva API Recent Developments 12.6 Symed Labs Limited 12.6.1 Symed Labs Limited Corporation Information 12.6.2 Symed Labs Limited Overview 12.6.3 Symed Labs Limited Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.6.4 Symed Labs Limited Deferasirox API Product Description 12.6.5 Symed Labs Limited Recent Developments 12.7 Neuland Laboratories 12.7.1 Neuland Laboratories Corporation Information 12.7.2 Neuland Laboratories Overview 12.7.3 Neuland Laboratories Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.7.4 Neuland Laboratories Deferasirox API Product Description 12.7.5 Neuland Laboratories Recent Developments 12.8 Parabolic Drugs Limited 12.8.1 Parabolic Drugs Limited Corporation Information 12.8.2 Parabolic Drugs Limited Overview 12.8.3 Parabolic Drugs Limited Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.8.4 Parabolic Drugs Limited Deferasirox API Product Description 12.8.5 Parabolic Drugs Limited Recent Developments 12.9 YUNG ZIP CHEMICAL INDUSTRIAL 12.9.1 YUNG ZIP CHEMICAL INDUSTRIAL Corporation Information 12.9.2 YUNG ZIP CHEMICAL INDUSTRIAL Overview 12.9.3 YUNG ZIP CHEMICAL INDUSTRIAL Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.9.4 YUNG ZIP CHEMICAL INDUSTRIAL Deferasirox API Product Description 12.9.5 YUNG ZIP CHEMICAL INDUSTRIAL Recent Developments 12.10 Erregierre SpA 12.10.1 Erregierre SpA Corporation Information 12.10.2 Erregierre SpA Overview 12.10.3 Erregierre SpA Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.10.4 Erregierre SpA Deferasirox API Product Description 12.10.5 Erregierre SpA Recent Developments 12.11 Glenmark Pharmaceuticals 12.11.1 Glenmark Pharmaceuticals Corporation Information 12.11.2 Glenmark Pharmaceuticals Overview 12.11.3 Glenmark Pharmaceuticals Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.11.4 Glenmark Pharmaceuticals Deferasirox API Product Description 12.11.5 Glenmark Pharmaceuticals Recent Developments 12.12 Cipla 12.12.1 Cipla Corporation Information 12.12.2 Cipla Overview 12.12.3 Cipla Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.12.4 Cipla Deferasirox API Product Description 12.12.5 Cipla Recent Developments 12.13 Sun Pharmaceutical Industries Ltd. 12.13.1 Sun Pharmaceutical Industries Ltd. Corporation Information 12.13.2 Sun Pharmaceutical Industries Ltd. Overview 12.13.3 Sun Pharmaceutical Industries Ltd. Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.13.4 Sun Pharmaceutical Industries Ltd. Deferasirox API Product Description 12.13.5 Sun Pharmaceutical Industries Ltd. Recent Developments 12.14 Jubilant Pharma 12.14.1 Jubilant Pharma Corporation Information 12.14.2 Jubilant Pharma Overview 12.14.3 Jubilant Pharma Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.14.4 Jubilant Pharma Deferasirox API Product Description 12.14.5 Jubilant Pharma Recent Developments 12.15 CTX Lifesciences 12.15.1 CTX Lifesciences Corporation Information 12.15.2 CTX Lifesciences Overview 12.15.3 CTX Lifesciences Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.15.4 CTX Lifesciences Deferasirox API Product Description 12.15.5 CTX Lifesciences Recent Developments 12.16 Waterstone Pharmaceuticals Inc. 12.16.1 Waterstone Pharmaceuticals Inc. Corporation Information 12.16.2 Waterstone Pharmaceuticals Inc. Overview 12.16.3 Waterstone Pharmaceuticals Inc. Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.16.4 Waterstone Pharmaceuticals Inc. Deferasirox API Product Description 12.16.5 Waterstone Pharmaceuticals Inc. Recent Developments 12.17 Bal Pharma Ltd. 12.17.1 Bal Pharma Ltd. Corporation Information 12.17.2 Bal Pharma Ltd. Overview 12.17.3 Bal Pharma Ltd. Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.17.4 Bal Pharma Ltd. Deferasirox API Product Description 12.17.5 Bal Pharma Ltd. Recent Developments 12.18 Curequest Lifescience 12.18.1 Curequest Lifescience Corporation Information 12.18.2 Curequest Lifescience Overview 12.18.3 Curequest Lifescience Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.18.4 Curequest Lifescience Deferasirox API Product Description 12.18.5 Curequest Lifescience Recent Developments 13 Industry Chain and Sales Channels Analysis 13.1 Deferasirox API Industry Chain Analysis 13.2 Deferasirox API Key Raw Materials 13.2.1 Key Raw Materials 13.2.2 Raw Materials Key Suppliers 13.3 Deferasirox API Production Mode & Process 13.4 Deferasirox API Sales and Marketing 13.4.1 Deferasirox API Sales Channels 13.4.2 Deferasirox API Distributors 13.5 Deferasirox API Customers 14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 14.1 Deferasirox API Industry Trends 14.2 Deferasirox API Market Drivers 14.3 Deferasirox API Market Challenges 14.4 Deferasirox API Market Restraints 15 Key Finding in The Global Deferasirox API Study 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

...

【掲載企業】

Piramal Enterprises Limited、Alkaloids Corporation、Zhejiang Hengkang Pharmaceutical、Om Pharmaceutical Industries、Teva API、Symed Labs Limited、Neuland Laboratories、Parabolic Drugs Limited、YUNG ZIP CHEMICAL INDUSTRIAL、Erregierre SpA、Glenmark Pharmaceuticals、Cipla、Sun Pharmaceutical Industries Ltd.、Jubilant Pharma、CTX Lifesciences、Waterstone Pharmaceuticals Inc.、Bal Pharma Ltd.、Curequest Lifescience

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のデフェラシロクスAPI市場インサイト・予測(~2027)(Global Deferasirox API Market Insights and Forecast to 2027)]についてメールでお問い合わせはこちらでお願いします。